Triple Negative Breast Cancer
Showing NaN - NaN of 26
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023
Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Positive
- Sacituzumab Govitecan-hziy
- +5 more
-
Anchorage, Alaska
- +245 more
Jan 12, 2023
NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)
Recruiting
- Non-small Cell Lung Cancer
- +11 more
-
Birmingham, Alabama
- +32 more
Jan 4, 2023
Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab, Paclitaxel, Dose-dense Doxorubicin or dose-dense Epirubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Atezolizumab
- +3 more
-
Concord, California
- +429 more
Dec 12, 2022
Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029
Terminated
- Colorectal Cancer
- +6 more
- GEN1029 (HexaBody®-DR5/DR5)
-
New Haven, Connecticut
- +5 more
Nov 11, 2022
HER2-negative Breast Cancer, Triple Negative Breast Cancer Trial in France, Germany, Ireland (Capecitabine, Carboplatin,
Recruiting
- HER2-negative Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +3 more
-
Brasschaat, Belgium
- +161 more
Nov 2, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)
Completed
- Melanoma
- +6 more
- Combination of NKTR-214 + nivolumab
-
La Jolla, California
- +57 more
Jun 22, 2022
Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)
Recruiting
- Triple Negative Breast Cancer
- Ipatasertib
- +4 more
-
Amadora, Lisboa, Portugal
- +16 more
Jun 10, 2022
Triple Negative Breast Cancer Trial in Spain (Carboplatin, Gemcitabine, Nadunolimab)
Recruiting
- Triple Negative Breast Cancer
- Carboplatin
- +2 more
-
Málaga, Andalucía, Spain
- +11 more
Feb 15, 2022
Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +5 more
- MGC018
- retifanlimab
-
Santa Monica, California
- +19 more
Feb 14, 2022
Solid Tumors, NSCLC, Urothelial Carcinoma Trial in Worldwide (GEN1046, GEN1046 in combination with docetaxel (in a single
Recruiting
- Solid Tumors
- +6 more
- GEN1046
- +2 more
-
Phoenix, Arizona
- +40 more
Jan 14, 2022
Triple Negative Breast Cancer Trial in Lleida, Madrid, Valencia (Combination, Palbociclib + Binimetinib)
Recruiting
- Triple Negative Breast Cancer
- Combination, Palbociclib + Binimetinib
-
Lleida, Spain
- +7 more
Sep 1, 2021
Triple Negative Breast Cancer Trial in Worldwide (SAR566658 (ACT14884))
Terminated
- Triple Negative Breast Cancer
- SAR566658 (ACT14884)
-
Leuven, Belgium
- +12 more
Aug 11, 2021
Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)
Completed
- Triple Negative Breast Cancer
- +3 more
-
Boston, Massachusetts
- +19 more
Jul 12, 2021
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Triple Negative Breast Cancer Trial in Worldwide (CAN04,
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- CAN04
- +3 more
-
Salzburg, Austria
- +27 more
Aug 4, 2021
Triple Negative Breast Cancer Trial in Worldwide (Cyclophosphamide, Placebo, Doxorubicin)
Completed
- Triple Negative Breast Cancer
- Cyclophosphamide
- +5 more
-
Scottsdale, Arizona
- +157 more
Jan 15, 2021
Triple Negative Breast Cancer Trial in Worldwide (Tivozanib Hydrochloride, paclitaxel, Placebo)
Terminated
- Triple Negative Breast Cancer
- Tivozanib Hydrochloride
- +2 more
-
Birmingham, Alabama
- +53 more
Oct 5, 2020